Gunderson Dettmer represents Syapse Inc in latest financing round

November 14, 2017Client News

Gunderson Dettmer served as lead counsel to Syapse Inc in its $30 million Series D financing from Ascension Ventures, GE Ventures, Intermountain Healthcare Innovation Fund, Safeguard Scientifics and Social Capital, as well as new investors Amgen Ventures, Medidata Solutions, Merck Global Health Innovation Fund and Roche Venture Fund.

The Gunderson Dettmer deal team was led by corporate partner Dan O’Connor along with partner and co-head of the Intellectual Property Group Colin Chapman, partner and leader of the Employment and Labor Law group Greg Lemmer as well as corporate and securities associates Darin See and Ibrahim Elshamy.

Syapse works with health systems to implement precision medicine programs across their organizations, enabling oncologists to deliver personalized care to every patient who needs it.

For further details, a press release can be seen here.